Biomarker Research

Papers
(The H4-Index of Biomarker Research is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma146
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes141
Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021120
ROR1 CAR-T cells and ferroptosis inducers orchestrate tumor ferroptosis via PC-PUFA2115
Gene therapy for polygenic or complex diseases112
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors104
New insights into the function of Interleukin-25 in disease pathogenesis95
PET-based radiomics visualizes tumor-infiltrating CD8 T cell exhaustion to optimize radiotherapy/immunotherapy combination in mouse models of lung cancer94
Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer92
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation90
Current and emerging therapies for primary central nervous system lymphoma84
Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia84
Novel strategies for immuno-oncology breakthroughs with cell therapy82
Advances in the DNA methylation hydroxylase TET174
Minimal residual disease in multiple myeloma: current status71
Tumor reversion: a dream or a reality70
Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial65
The Wnt/β-catenin signalling pathway in Haematological Neoplasms59
The intriguing roles of Siglec family members in the tumor microenvironment56
SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma55
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies54
Mitochondrial transfer in hematological malignancies53
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation52
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model52
FGL1 and FGL2: emerging regulators of liver health and disease47
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma46
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation46
Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases44
CardioAtlas: deciphering the single-cell transcriptome landscape in cardiovascular tissues and diseases43
Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas43
Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study43
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics42
Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 20242
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer42
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma41
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients41
The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis40
Molecular mechanisms and clinical applications of exosomes in prostate cancer40
The emerging role of RNA N6-methyladenosine methylation in breast cancer40
Decoding burn trauma: biomarkers for early diagnosis of burn-induced pathologies40
0.099503040313721